H
ALXN

Hexavest’s Alexion Pharmaceuticals ALXN Stock Holding History

Hexavest’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,552
Closed -$836K – 311
2021
Q2 		$836K Buy
4,552
+3,802
+507% +$653K 0.04% 191
2021
Q1 		$115K Buy
750
+689
+1,130% +$107K 0.01% 275
2020
Q4 		$10K Hold
61
– – ﹤0.01% 337
2020
Q3 		$7K Hold
61
– – ﹤0.01% 386
2020
Q2 		$7K Buy
+61
New +$6.48K ﹤0.01% 395
2019
Q4 		– Sell
-77
Closed -$8K – 498
2019
Q3 		$8K Hold
77
– – ﹤0.01% 488
2019
Q2 		$10K Buy
+77
New +$9.92K ﹤0.01% 491

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return